Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
A new $25M fund aims to give UK mental health startups a shot in the arm

From TechCrunch

By Mike Butcher

December 12, 2024

A new $25M fund aims to give UK mental health startups a shot in the arm

A new $25M fund aims to give UK mental health startups a shot in the arm

In case you hadn’t noticed, there are a lot of mental health startups out there these days, many of which were prompted to launch following the pandemic and the subsequent widespread focus on mental health. However, they often have scant relationships with clinical trials or healthcare systems.

A new venture from the U.K.’s KHP Ventures, is planning to correct that by raising a new £20 million ($25.5 million) fund specifically aimed at accelerating startups that are addressing depression, anxiety and psychosis.

Wellcome, a charitable foundation, is supporting the fund as its anchor investor, committing £8 million ($10.2 million).

The fund is expected to close early in 2025, aiming to raise a total of £20 million ($25.5 million). It will invest between £250,000 to £1 million ($319,000 to $1.3 million) in startups.

KHP is an existing collaboration between King’s College London, King’s College Hospital NHS Foundation Trust, and Guy’s and St Thomas’ Hospital NHS Foundation Trust. It invests in healthcare and medtech startups that aim to have operations in the U.K.. KHP’s brand new Innovations in Mental Health Fund will be supported by the U.K.’s largest mental health provider, the South London and Maudsley NHS Foundation Trust.

Initially, the firm is running a free, 12-week immersion program. Startups selected will be evaluated for eventual investment by the fund. The program is open to startups across the world, but they must show a focus on developing solutions for the U.K. market.

Startups that attain investment will receive support for developing clinical and academic trials, accessing patient and service data, and testing their product in a live environment. They will also get access to patient focus groups, experts, clinicians, and academics, thanks to the partnership with the South London and Maudsley NHS Foundation Trust.

The search for mental health services is on the rise. Around 3.8 million people were in contact with the U.K.’s NHS mental health services over the last year, up almost two-fifths compared to before the pandemic. This includes more than 1 million children, with 16-year-olds most likely to be seeking support.

“We felt that there was a need for a thematic fund in mental health,” said Dr Pooja Sikka, the founding general partner of the Innovations in Mental Health Fund. “There are a lot of startups in this space and lots of technology potential in this space, but there wasn’t the right capital flowing to it.”

“Our anchor investor, the Wellcome Trust, is trying to raise the bar on scaling mental health, and in particular, a thesis on digital mental health,” she added.

Sikka noted that the population’s mental health has gotten worse and it’s affecting every section of society. But at the same time, she believes we’ve understood the potential of technology. “Really what we wanted the funding to do here was to create a very specific pool of capital, but with the right support for the startups,” she said.

“Millions of people are held back by mental health problems. There is a pressing need for new and improved ways that we can help them live the lives they wish to lead,” Elena Netsi, research lead in digital mental health at Wellcome, said in a statement.

View original article on techcrunch.com

Most Recent

Daniel Ek’s body-scanning startup Neko Health raises another $700M

Daniel Ek’s body-scanning startup Neko Health raises another $700M

Neko Health has developed proprietary body-scanning technology, which it couples with bloodwork, to assess a person's health.

Jul 15, 2026

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

Jul 14, 2026

Reed Jobs would rather talk about curing cancer than his last name

Reed Jobs would rather talk about curing cancer than his last name

When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its post-pandemic crash. Now, the venture outfit has a team of 17; a cluster of blockbuster drugs are all losing patent protection in roughly the same window, creating all kinds of new opportunities; and AI has gone from a curiosity to, in Jobs' words, a huge part of what Yosemite does. "I didn't expect Yosemite to be moving this fast," he said.

Jul 11, 2026

AI slop company wants to open 5,000 wellness spas. It's starting in Union Square

AI slop company wants to open 5,000 wellness spas. It's starting in Union Square

Midjourney, best known for AI imagery, revealed a new health division called Midjourney Medical. It leased 23,000 sq ft across four floors at 300 Grant Avenue in Union Square for a wellness center mixing spa amenities with full-body ultrasound scanners. The facility will include roughly ten scanners plus saunas, hot tubs, and cold plunges. Users must fully submerge in water for the 60-second radiation-free scan, which the firm claims uses just sound and water and 60 seconds. The spa is scheduled to open late 2027 and run around the clock. The scans are not yet FDA-approved, and pricing was not disclosed. Leaders plan to install 50,000 machines worldwide over six years, needing about 5,000 locations and 20 billion dollars; the target is one billion scans per year.

Jun 18, 2026

Similar Posts

Temasek’s Sheares Healthcare backs Asia-focused mental health startup Thoughtfull

Temasek’s Sheares Healthcare backs Asia-focused mental health startup Thoughtfull

Southeast Asia’s mental health startups are getting more investor attention. Last week, Intellect announced a strategic investment from IHH Healthcare, Asia’s largest private healthcare group. Now Thoughtfull, another digital mental health platform focused on Asia, has raised $4 million in a pre-Series A round led by Sheares Healthcare Group. Sheares is a wholly-owned subsidiary of […]

Mar 22, 2023

Mental health startup Intellect partners with Asia’s largest private healthcare group

Mental health startup Intellect partners with Asia’s largest private healthcare group

Intellect, the Singapore-based mental health platform that now serves over three million users in 20 countries, is getting ready for a new phase of growth after striking a strategic partnership with IHH Healthcare, Asia’s largest private healthcare group. IHH Healthcare will work with Intellect to develop and customize digital mental health programs for its patients, […]

Mar 14, 2023

Teale, your mental health companion at work, raises $11 million

Teale, your mental health companion at work, raises $11 million

French startup Teale has secured a funding round of $11 million earlier this summer (€10 million). The company provides a mental health platform for employees and helps HR managers when it comes to preventing burnout or quiet quitting. Alter Equity and Bpifrance’s Digital Venture fund are leading the Series A funding round. Existing investors Isai […]

Aug 30, 2023

Can you build a startup without sacrificing your mental health? Bonobos founder Andy Dunn thinks so

Can you build a startup without sacrificing your mental health? Bonobos founder Andy Dunn thinks so

Bonobos founder Andy Dunn is back in the builder’s seat, working on an in-person social media platform called Pie. But the biggest lessons he learned from his $310 million Bonobos exit don’t have as much to do with entrepreneurship as they do with staying sane. When Dunn was in college, he was diagnosed with bipolar disorder, but he didn’t get adequate treatment until 2016, when he was hospitalized during a manic episode for the second time. “The manic state is just a disaster — that’s like bei

Nov 2, 2024

Most Recent

Daniel Ek’s body-scanning startup Neko Health raises another $700M

Daniel Ek’s body-scanning startup Neko Health raises another $700M

Neko Health has developed proprietary body-scanning technology, which it couples with bloodwork, to assess a person's health.

Jul 15, 2026

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

Jul 14, 2026

Reed Jobs would rather talk about curing cancer than his last name

Reed Jobs would rather talk about curing cancer than his last name

When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its post-pandemic crash. Now, the venture outfit has a team of 17; a cluster of blockbuster drugs are all losing patent protection in roughly the same window, creating all kinds of new opportunities; and AI has gone from a curiosity to, in Jobs' words, a huge part of what Yosemite does. "I didn't expect Yosemite to be moving this fast," he said.

Jul 11, 2026

AI slop company wants to open 5,000 wellness spas. It's starting in Union Square

AI slop company wants to open 5,000 wellness spas. It's starting in Union Square

Midjourney, best known for AI imagery, revealed a new health division called Midjourney Medical. It leased 23,000 sq ft across four floors at 300 Grant Avenue in Union Square for a wellness center mixing spa amenities with full-body ultrasound scanners. The facility will include roughly ten scanners plus saunas, hot tubs, and cold plunges. Users must fully submerge in water for the 60-second radiation-free scan, which the firm claims uses just sound and water and 60 seconds. The spa is scheduled to open late 2027 and run around the clock. The scans are not yet FDA-approved, and pricing was not disclosed. Leaders plan to install 50,000 machines worldwide over six years, needing about 5,000 locations and 20 billion dollars; the target is one billion scans per year.

Jun 18, 2026

Similar Posts

Temasek’s Sheares Healthcare backs Asia-focused mental health startup Thoughtfull

Temasek’s Sheares Healthcare backs Asia-focused mental health startup Thoughtfull

Southeast Asia’s mental health startups are getting more investor attention. Last week, Intellect announced a strategic investment from IHH Healthcare, Asia’s largest private healthcare group. Now Thoughtfull, another digital mental health platform focused on Asia, has raised $4 million in a pre-Series A round led by Sheares Healthcare Group. Sheares is a wholly-owned subsidiary of […]

Mar 22, 2023

Mental health startup Intellect partners with Asia’s largest private healthcare group

Mental health startup Intellect partners with Asia’s largest private healthcare group

Intellect, the Singapore-based mental health platform that now serves over three million users in 20 countries, is getting ready for a new phase of growth after striking a strategic partnership with IHH Healthcare, Asia’s largest private healthcare group. IHH Healthcare will work with Intellect to develop and customize digital mental health programs for its patients, […]

Mar 14, 2023

Teale, your mental health companion at work, raises $11 million

Teale, your mental health companion at work, raises $11 million

French startup Teale has secured a funding round of $11 million earlier this summer (€10 million). The company provides a mental health platform for employees and helps HR managers when it comes to preventing burnout or quiet quitting. Alter Equity and Bpifrance’s Digital Venture fund are leading the Series A funding round. Existing investors Isai […]

Aug 30, 2023

Can you build a startup without sacrificing your mental health? Bonobos founder Andy Dunn thinks so

Can you build a startup without sacrificing your mental health? Bonobos founder Andy Dunn thinks so

Bonobos founder Andy Dunn is back in the builder’s seat, working on an in-person social media platform called Pie. But the biggest lessons he learned from his $310 million Bonobos exit don’t have as much to do with entrepreneurship as they do with staying sane. When Dunn was in college, he was diagnosed with bipolar disorder, but he didn’t get adequate treatment until 2016, when he was hospitalized during a manic episode for the second time. “The manic state is just a disaster — that’s like bei

Nov 2, 2024